Skip to main content
. 2022 Jan 27;122(1):197–202. doi: 10.1007/s13760-022-01874-8

Table 1.

Patients’ characteristics at inclusion

Patients DBS group (n = 15) Drug-treated group (n = 14) Difference at inclusion (Mann–Whitney)
Age (years) 63 ± 6.4 66 ± 7.1 p = 0.24
Disease duration (years) 9.4 ± 5.2 10.1 ± 6.3 p = 0.7
Best UPDRS III 19 ± 8.5 20.2 ± 13.5 p = 0.78
Worst UPDRS III 57 ± 12.2 54.2 ± 15.5 p = 0.59
UPDRS-IV (dyskinesia) 8.4 ± 2.9 7.9 ± 3.3 p = 0.67
Best Schwab and England 93 ± 7 89 ± 11 p = 0.25
Worst Schwab and England 43 ± 19 51 ± 16 p = 0.23
Dopa equivalents/day (mg) 1115 ± 158 1070 ± 137 p = 0.8